ReviewInternational journal of molecular sciences2023

CRISPR/Cas9 as a New Antiviral Strategy for Treating Hepatitis Viral Infections.

Ulyana I Bartosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.